Delivery Order SPE2DB20D9331-SPE2DB21FL1Q4
Award Date 8/5/21
Potential Completion Date 8/26/21
Potential Value $3.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,249.10 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of November 16, 2022. DMS Pharmaceutical Group is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a larger...
- This federal contract award, valued at $1,654.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML, a medical product, with an ultimate completion date of August 6, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside used. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,654.44 firm fixed-price delivery order contract is for the provision of TISSUEBLUE 0.025% SYRINGE 0.5ML, a specialized pharmaceutical product. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
- This federal contract award is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML medical supplies to the Department of Defense (DoD) healthcare system. The $2,481.66 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid...
- This is a delivery order (SPE2DB24FSX02) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 2, 2024. The contract provides for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML, with a ceiling value of $1,605.48 and a completion date of April 23, 2024. The contract is a firm fixed-price arrangement. DMS Pharmaceutical Group Inc. is the prime contractor, and there are no set-aside designations indicated. This award is part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,963.32 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML medical products. The contract has an ultimate completion date of June 10, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $4,816.44 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. This delivery order,...
- This federal contract award, with ID SPE2DB20D9331 and SPE2DB23FL1M2, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.56 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML, a pharmaceutical product, with a completion date of September 21, 2023. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,210.96, is for the supply of a pharmaceutical product, Tissueblue 0.025% Syringe 0.5ML, to support the recurring medical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to...
- On August 18, 2025, the Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc. for TISSUEBLUE 0.025% Syringe 0.5ML. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the...